Our current understanding of the induction of pluripotency by defined factors indicates that this process occurs in discrete stages characterized by specific alterations in the cellular transcriptome and epigenome. However, the final phase of the reprogramming process is incompletely understood. We sought to generate tools to characterize the transition to a fully reprogramed state. We used combinations of stem cell surface markers to isolate colonies emerging after transfection of human fibroblasts with reprogramming factors and then analyzed their expression of genes associated with pluripotency and early germ lineage specification. We found that expression of a subset of these genes, including the cell-cell adhesion molecule CDH3, characterized a late stage in the reprogramming process. Combined live-cell staining with the antibody GCTM-2 and anti-CDH3 during reprogramming identified colonies of cells that showed gene expression patterns very similar to those of embryonic stem cell or established induced pluripotent stem cell lines, and gave rise to stable induced pluripotent stem cell lines at high frequency. Our findings will facilitate studies of the final stages of reprogramming of human cells to pluripotency and will provide a simple means for prospective identification of fully reprogrammed cells. STEM CELLS TRANSLATIONAL MEDICINE 2016;5:870-882 
INTRODUCTION
The discovery of the induction of pluripotency by defined factors has raised new possibilities for the use of stem cells in disease modeling and regenerative medicine [1] . Since the initial description of induced pluripotent stem cells (iPSCs), advances in reprogramming technology have provided alternatives to retroviral integration and eliminated the need for permanent alteration to the cellular genome in the process [2] . However, concerns about the genetic integrity and differentiation capacity of iPSC remain [3, 4] .
The reprogramming process has been extensively scrutinized at the molecular level, and many new insights into the epigenetic basis of induction of pluripotency have emerged [5] . Critical to this analysis has been the availability of molecular landmarks that reproducibly chart the progress of reprogramming within the cell. The availability of appropriate markers enhances efficient selection of bona fide reprogrammed cells or colonies and helps to facilitate mechanistic studies through identification of well-defined intermediate stages during the process. Although genetically engineered cell lines with reporters introduced into specific loci that undergo reactivation during reprogramming provide powerful tools for analysis [6] , it is not practical to introduce such modifications into hundreds of fibroblast or blood cell isolates for large-scale derivation. Cell surface markers identified by monoclonal antibodies, therefore, have an important role in the identification and selection of reprogrammed colonies and in monitoring progress of the reprogramming process itself [7] .
Lowry et al. [8] were the first to demonstrate that live-cell staining with the antibody TRA-1-60 could be used to identify fully reprogrammed human iPSCs (hiPSCs). Chan et al. [9] confirmed and extended this observation; in this latter study, other markers of the pluripotent state, including the canonical stem cell surface marker SSEA-4, were not sufficient to distinguish fully reprogrammed cells from partially or incompletely reprogrammed cells. Only a combination of several markers plus assessment of intensity of staining with the DNA dye Hoechst 33258 could successfully identify reprogrammed cells. Another study described the use of a combination of SSEA-4, TRA-1-60, and CD30 to isolate fully reprogrammed cells through flow cytometry [10] . Tanabe et al. [11] showed that TRA-1-60-positive cells did not always progress to the fully reprogrammed state, and they identified maturation as a key roadblock in reprogramming. Recently Takahashi et al. [12] used TRA-1-60 staining to isolate cells at a late stage of reprogramming that expressed markers of the primitive streak, and they suggested these cells represented an intermediate in the reprogramming process, providing further evidence that cells expressing this marker have not completed the reprogramming process.
In this study, we use live-cell staining with several combinations of antibodies to isolate colonies that emerged following transfection of fibroblasts with a PiggyBac transposon vector (System Biosciences, Palo Alto, CA, https://www.systembio.com) containing the four reprogramming factors (POU5F1, SOX2, KLF4, CMYC) and examined gene expression in these colonies using a panel of genes including key pluripotency transcription factors, cell surface and secreted molecules involved in stem cell renewal, and lineage-specific transcription factors. We used previous analyses of gene expression in bulk populations and immunologically defined subsets of human pluripotent stem cells from our laboratory and others to identify a novel panel of markers that characterized different stages in a continuous hierarchy from self-renewing subpopulations to lineage primed cells [13] [14] [15] . The results showed that surface markers can be used to select colonies with specific patterns of gene expression at later stages of reprogramming, thereby defining a transition late in the reprogramming process and allowing facile selection of colonies of fully reprogrammed cells.
MATERIALS AND METHODS
Standard and xeno-free culture systems for human pluripotent stem cells, and for derivation and characterization of hiPSC including Fluidigm gene expression analysis (Fluidigm Corporation, South San Francisco, CA, https://www.fluidigm.com), are described in the supplemental online data.
Marker Expression During Reprogramming
Low passage human fetal dermal fibroblasts (hFDFs) were nucleofected with 4 mg of pPB.OSKM-puDtk transposon and 2 mg of pCyL43:PB transposase plasmids as described in the supplemental online data. After resuspension in fibroblast culture medium, nucleofected cells were plated in two-well chamber slides coated with 0.5 mg per cm 2 of vitronectin/fibronectin at a density of 1 3 10 3 cells per cm 2 . Fibroblast medium was changed the day after transfection and every other day until day 5 when the medium was replaced with XF-KSR human embryonic stem cell (hESC) medium (ThermoFisher Scientific, Waltham, MA, http://thermofisher.com) with feeding continuing every other day. Nontransfected hFDFs were also plated at the same density as negative controls for antibody staining. Beginning on day 3 and ending on day 24, slides were fixed with 4% paraformaldehyde in phosphate-buffered saline at 3-day intervals. Fixed slides were stained with the following pluripotency marker combinations on days 3, 6, 9, 12, 15, 18, 21, and 24: TRA-1-60/GDF3, GCTM-2/EPCAM, POU5F1/DNMT3B, NANOG/ CDH1, EPCAM/DNMT3B, and EPCAM/CDH1 (the sources of these antibodies are listed in the supplemental online data). Staining conditions were identical to those described previously.
Pluripotency marker expression was compared with the positive control hiPSC line J1. Three categories were utilized to score the staining: negative (matches negative control/background), positive (staining intensity above background with correct cellular localization), and intense (staining intensity resembles positive control staining). Quantification by integration of fluorescence above individual nuclei using ImageJ software (NIH, Bethesda, MD, https://imagej.nih.gov/ij) supported the three-category scoring for marker positivity, although assessment of marker staining was performed visually. All colonies present on the slides were scored according to the previously indicated criteria and were noted to be double-negative, single-positive, or double-positive for each marker pair. All intense staining colonies were also scored/included in the positive category.
Selection of Colonies for Fluidigm BioMark HD Expression Profiling of Single Reprogramming Foci
Low passage hFDFs were nucleofected with 4 mg of pPB.OSKMpuDtk transposon and 2 of mg pCyL43:PB transposase plasmids as described in Marker Expression During Reprogramming, and then they were plated at a density of 1 3 10 3 cells per cm 2 onto 35-mm cell culture dishes coated with 0.5 mg per cm 2 of vitronectin/ fibronectin. Fibroblast medium was changed the day after transfection and every other day until day 5 when the medium was replaced with XF-KSR hESC medium with feeding continuing every other day.
On days 10, 20, and 30, reprogramming dishes were stained by live-cell staining with the marker combinations GCTM-2/ EPCAM and TRA-160/CDH1 and CDH3/ GCTM-2 as follows. Primary and secondary antibodies were diluted into XF-KSR hESC medium and incubated consecutively for 20 minutes at 37°C with three sterile phosphate-buffered saline (PBS) washes following each incubation. One milliliter of sterile PBS was added to each 35-mm cell culture dish for imaging with a Zeiss Axio Vert.A1 (Zeiss, Jena, Germany, http://www.zeiss.com). Hoechst dye was added during the secondary antibody incubation for nuclear counterstaining. Primary and secondary antibody pairings were as follows: GCTM-2/Alexa Fluor 488 goat anti-mouse IgM (ThermoFisher Scientific); EPCAM/Alexa Fluor 568 goat anti-mouse IgG1 (ThermoFisher Scientific); TRA-1-60/Alexa Fluor 594 goat antimouse IgG1 (ThermoFisher Scientific); and CDH1/Alexa Fluor 488 goat anti-mouse IgM. In subsequent experiments, dishes containing reprogramming foci were stained at day 30 with a combination of anti-CDH3 (MAB 861; R&D Systems Inc., Minneapolis, MN, http://www.rndsystems.com) followed by Alexa Fluor 488 goat anti-mouse IgG1 and GCTM-2 followed by Alexa Fluor 594 goat anti-mouse IgM. Double-negative and double-positive colonies were imaged and isolated by manual dissection for expression analysis. Nontransfected hFDFs (negative control) and hiPSCs/hESCs (positive controls) were also live-cell stained and isolated.
Isolated colonies were immediately lysed in 250 ml of lysis buffer contained in the Qiagen RNeasy Micro Kit (Qiagen, Hilden, Germany, https://www.qiagen.com) and RNA was extracted following the Qiagen protocol.
Live-Cell Selection and Characterization of hiPSCs Using GCTM-2/EPCAM and TRA-1-60/CDH1
Low-passage hFDFs were nucleofected and plated as described in the previous section. After 30 days, reprogramming dishes were live-cell stained with the marker pairs GCTM-2/EPCAM and TRA-1-60/CDH1. Staining conditions were identical to the previous section except that Hoechst dye was not added. Double-positive and double-negative foci were imaged, isolated by manual dissection, and transferred to fresh XF culture dishes. hiPSCs exhibiting attachment and outgrowth were continually passaged as long as they were viable, and they were observed for morphological characteristics.
Reprogrammed colonies were plated in eight-well chamber slides for immunocytochemistry and stained for the following markers: TRA-1-60/GDF3, GCTM-2/EPCAM, POU5F1/DNMT3B, NANOG/CDH1, EPCAM/DNMT3B,EPCAM/CDH1,SSEA-4/SOX2,andalkalinephosphatase. Live-cell-selected hiPSCs were also prepared for spin-embryoid body (see supplemental online data). differentiation assays.
Selection of Reprogrammed Cells With CDH3 LiveCell Staining
Human WS1 (ATCC, Manassas, VA, http://www.atcc.org) and BJ (Stemgent, Lexington, MA, https://www.stemgent.com) fibroblasts were cultured in Dulbecco's modified Eagle's medium (DMEM) with high glucose, 10% fetal bovine serum (FBS), 100 U/ml of penicillin, and 100 mg/ml of streptomycin. iPSCs were cultured on irradiated mouse embryonic fibroblasts (MEFs) (2.5 3 10 4 per cm 2 ) on gelatin-coated plates in knockout serum replacement (KSR) medium containing 20 ng/ml of FGF2 (EMD Millipore, Darmstadt, Germany, http://www.emdmillipore.com): DMEM/F-12 with GlutaMAX (ThermoFisher Scientific), 20% KSR, 0.1 mM of MEM-NEAA, 0.1 mM of b-mercaptoethanol, 50 U/ml of penicillin, and 50 mg/ml of streptomycin. iPSC colonies were subcultured weekly as small clusters using dispase (1.75 U/ml) and gentle dissociation with a Pasteur pipette. MEF carryover was minimized during passage by allowing iPSC clumps to settle under gravity in a conical tube, then aspirating the medium above the pellet before seeding. The optimal split ratio ranged from 1:5 to 1:20 and was determined empirically for each individual iPSC line. KSR media was replenished daily.
Fibroblasts were reprogrammed to iPSCs with nonintegrating episomal vectors containing six reprogramming factors (OCT4, SOX2, KLF4, L-MYC, LIN28, and shRNA for p53) according to Okita et al. [16] . Six hundred thousand fibroblasts were transfected with 1 mg each of pCXLE-hOCT4-shP53, pCXLE-hSK, and pCXLE-hUL plasmids (Addgene, Cambridge, MA, https://www.addgene.org) using nucleofection (Lonza Nucleofector; Lonza Group, Basel, Switzerland, http://www.lonza.com). Seven days postnucleofection, fibroblasts were trypsinized and 1 3 10 5 cells were replated onto 3-3 6-cm gelatin-coated plates containing irradiated MEFs. The following day, fibroblast media was changed to KSR medium with 20 ng/ml of FGF2; media was replenished every other day. Primary iPSC colonies emerged within approximately 20 days.
On day 26 postnucleofection, emerging colonies were coimmunolabeled with GCTM-2 (hybridoma supernatant, neat) and either mouse anti-human CDH3 (1:20) or mouse anti-human EPCAM (1:50) for 20 minutes at 37°C in a 5% CO 2 incubator (2 ml of antibody solution per 6-cm plate). Cells were rinsed twice with PBS then incubated for 20 minutes at 37°C with isotype-specific secondary antibodies: goat anti-mouse IgG1-Alexa Fluor 488 and goat anti-mouse IgM-Alexa Fluor 594 (both 1:500 in KSR medium). Cells were then rinsed twice in PBS, imaged on a Nikon Eclipse TE2000U inverted microscope with NIS Elements software (Nikon, Tokyo, Japan, http://www.nikon.com/), and doublepositive colonies (GCTM-2+CDH3+ or GCTM-2+EPCAM+) were marked on each plate. These colonies were mechanically selected under a Leica MZ6 stereomicroscope in a biosafety hood using a 21-g needle and transferred to organ culture plates with MEFs (denoted P0 for passage 0). Clonal iPSC colonies were expanded for 9 days then subcultured by mechanical dissection each week until they exhibited stable, robust growth of morphologically undifferentiated colonies, after which point they were passaged with dispase as per conventional methods for propagating established iPSC lines (usually within 1 to 2 passages).
Characterization of selected iPSC lines, including GCTM-2/ CD9 flow cytometry and multilineage differentiation in embryoid body assays, was carried out as described in the supplemental online data.
RESULTS

Expression of Stem Cell Markers in Reprogramming Colonies Reaches Maximum at Day 21
Many studies of reprogramming have analyzed the process by studying whole populations of cells or cellular subpopulations fractionated by flow cytometry using particular markers. In this work, we focused on analyzing growing colonies that emerged from a single clonal reprogramming event, for two reasons. First, the selection of human iPSCs is often carried out at the colony level, to maximize survival and recovery of reprogrammed cells. Second, in situ analysis of colonies can provide insight into how the progeny of single transfected cells evolve, a feature that is obscured by harvesting cells prior to analysis.
We monitored expression of cell surface glycoproteins (TRA-1-60, GCTM-2) cell adhesion molecules (CDH1, EPCAM); a growth factor (GDF3); and transcription factors (POU5F1, SOX2, NANOG, DNMT3B) in expanding foci of transfected cells (supplemental online Fig. 1 ) every 3 days (days 3, 6, 9, 12, 15, 18, 21, 24) following addition of reprogramming factors. The GCTM-2 antibody recognizes a cell surface glycoprotein that bears the TRA-1-60 and TRA-1-81 epitopes. The following marker combinations were used: TRA-1-60/GDF3 (Fig. 1A) , EPCAM/GCTM-2 (Fig. 1B) , DNMT3B/ POU5F1 (supplemental online Fig. 2A ), CDH1/NANOG (Fig. 1C) , EPCAM/DNMT3B (supplemental online Fig. 2B ), and EPCAM/ CDH1 (Fig. 1D) . Colonies of varying staining positivity and intensity for all markers were detected at each time point from day 9 onward, indicating nonuniform reprogramming. Most colonies showed heterogeneity of staining, with only subsets of cells within the colonies expressing the markers. As the reprogramming process progressed, the proportion of cells within a colony that stain positive for particular markers increased. Positive staining for POU5F1 (supplemental online Fig. 2A ) in foci indicated that the majority of the expanding colonies had undergone transfection and were expressing the transgene. The selected colonies illustrated in these figures are representative of the strongest staining at each time point.
The time course of antibody staining, determined by counting the incidence and intensity of stained colonies, is depicted in Figure 2 . Staining was classified as positive (correct subcellular localization, above background) or intense (correct subcellular localization at a level similar to positive control hESC or iPSC lines). A colony was scored positive even if a small proportion of cells within it exhibited expression. As the reprogramming process progressed, the percentage of colonies staining positively for the markers increased. Intense POU5F1 staining was observed from day 3. GDF3-and NANOG-positive colonies appeared early (days 6-9, respectively). The cell surface markers including cellcell adhesion molecules did not begin to appear until approximately day 12, as did DNMT3B. Cells that were double-positive for sets of markers began to appear on days 12-15, and intensely staining foci began to appear on days 15-18. Intense staining, including double-positive intense staining, was rarely seen in more than 10% of colonies and peaked by day 21. Each chamber slide well contained 100 to 200 reprogramming foci for analysis. With an initial seeding density of 5 3 10 3 cells/well, this represents a reprogramming efficiency of approximately 3%.
Coexpression of Cell Surface Markers Identifies Reprogramming Foci With Transcriptional Profiles Closer to Pluripotent Cells
To carry out transcriptional profiling of emerging reprogrammed colonies, we performed live-cell staining with the cell surface marker combinations GCTM-2/EPCAM and TRA-1-60/CDH1 (Fig.  3) at several time points to select double-positive emerging colonies of cells undergoing reprogramming (reprogramming foci) from fibroblasts. As a positive control, we used the embryonic stem cell line USC01 and hiPSC cell lines AA4 and AE1, which expressed markers of pluripotency and differentiated into derivatives of all three germ layers in embryoid body or teratoma assays [17] . These control cell lines exhibited strong positivity for all four markers (Figs. 3A, 3B, 3D , and 3E). GD30F (Fig. 3C) is an example of intense GCTM-2/EPCAM staining arising after 30 days of reprogramming and TD302B (Fig. 3F) is a reprogramming focus with intense CDH1/TRA-1-60 staining after 30 days. Double-positive and double-negative colonies were harvested for RNA expression analysis at days 10, 20, and 30 following transfection. All colonies isolated at day 10 after live-cell staining were marker-negative, as expected from the reprogramming timeline study. By day 20, several colonies exhibited intense staining with increasing number and size of strongly staining colonies by day 30.
We analyzed more than 150 foci along with positive and negative controls for expression of a panel of pluripotency and early lineage genes by quantitative RT-polymerase chain reaction using the Fluidigm system (Fig. 4) . Hierarchical cluster analysis of the data provides two major clusters along the vertical axis. The top vertical cluster (pluripotent) groups the positive control hESC and hiPSC cell lines with a majority of the day 30 double-positive samples and a few day 20 double-positive samples. The bottom vertical cluster (fibroblastic) groups the negative control hFDF samples along with the majority of the day 20 double-positive, all day 10 double-negative, and all day 20/30 double-negative samples. A few major clusters also appear along the horizontal (gene) axis. Mouse Pou5f1 is expressed strongly in some hiPSC and all reprogramming foci samples tested, indicating continued activity of the reprogramming transposon. Some genes were clearly upregulated in the pluripotency group but were also expressed in a subset of day 10 and day 20 negative colonies. These genes included DPPA3, NANOG, endogenous (human) POU5F1, LEFTY1, NODAL, TDGF1, ERBB3, and DNMT3B (gene clusters 1 and 2). This group of upregulated genes includes several A time course analysis of the proportion of foci expressing early upregulated genes (Fig. 5A) , and the corresponding data for late upregulated genes (Fig. 5B) , reflected the hierarchical clustering data. Although it is apparent that both classes of genes are expressed within an increasing proportion of foci over time, the early group demonstrates significant expression by day 10 with expression also noted in the day 20N and day 30N double-negative samples. The late group has very limited expression in doublenegative foci (day 10N, day 20N, day 30N) and double-positive foci isolated at day 20. By contrast, approximately half of the doublepositive foci isolated at day 30 show expression of these late genes. The expression differences between the fully reprogrammed hiPSC controls and day 30P foci are statistically significant for all the genes. The expression differences between day 20P and day 30P double-positive isolated foci are significant (p , .05) to highly significant (p , .01) for all genes except SOX2 and LCK. Furthermore, the expression differences between day 30P double-positive foci and day 30N double-negative foci are highly significant (p , .01) to very highly significant for the majority of late genes.
Examples of gene expression analysis for specific stained colonies are shown in supplemental online Figure 3 .
While this work was in progress, Cacchiarelli et al. [18] carried out an extensive transcriptional and epigenomic analysis of the induction of pluripotency in human fibroblasts using an inducible transgene system. The time course of expression of our early and late marker gene panels in their study is shown in supplemental online Figure 4 . The time course of their study is more compressed than ours, probably due to their use of an inducible transgene system, but the overall patterns are quite similar.
Selection Using Late Markers of Reprogramming Increases hiPSC Derivation Efficiency
Colonies exhibiting dual positivity for either set of markers showed dramatically higher derivation efficiency compared with negative colonies at day 30 (supplemental online Table 1 ). None of the marker-negative colonies gave rise to fully reprogrammed hiPSCs (defined by continuous growth and positive marker expression). Of 53 marker-negative colonies, 30 attached and exhibited outgrowths resembling partially reprogrammed hiPSCs. Only two of these lines could be serially cultivated for further characterization (T2Qn, T3Rn). Of the 73 marker-positive colonies subjected to livecell selection, 19 attached and exhibited outgrowths. Fourteen of these newly derived hiPSCs could be propagated beyond five passages and exhibited a fully reprogrammed state on the basis of colony morphology and staining, with the other five outgrowths showing a partially reprogrammed identity. With 14/75 live-cell selected foci generating hiPSCs with morphology suggestive of a fully reprogrammed state, the selection-based derivation efficiency was 19.2%. Several of these live-cell positively selected fully and partially reprogrammed colonies were propagated long-term and characterized by immunocytochemistry and embryoid body assays (supplemental online Figs. 5, 6 ). The live-cell selected, "fully" reprogrammed hiPSC line G4F demonstrates strong marker positivity for the pluripotency markers TRA-1-60, GCTM-2, GDF3, EPCAM, CDH1, SSEA-4, alkaline phosphatase, POU5F1, DNMT3B, NANOG, and SOX2 (supplemental online Fig. 5A-5H) . The live-cell selected, "partially" reprogrammed hiPSC line G5D also demonstrates positivity for each of the markers in this study (I-P), but the surface markers show patchy staining across the colonies. The nuclear markers also show limited areas of positivity across each colony.
The pluripotency of the live-cell selected, fully reprogrammed hiPSC line G4F was confirmed by the ability to generate cells representative of the three primary germ layers in embryoid body assays (positive immunostaining for NESTIN, AFP, and SMA confirming the presence of ectoderm, endoderm, and mesoderm lineage cells, respectively) (supplemental online Fig. 6 ).
Live-Cell Selection With CDH3 (P-Cadherin) Identifies Colonies Expressing a Full Complement of Pluripotency Markers
CDH3 was among the genes expressed in common between the positive controls and late reprogrammed double-positive colonies. Expression of CDH3 was easily detected by immunocytochemical staining of fixed positive control cell lines (supplemental online Fig.  7A ) or live-cell staining of reprogramming foci from day 20 onward (supplemental online Fig. 7B ). We selected primary colonies using live-cell staining with an antibody against CDH3 combined with GCTM-2 at day 30 following transfection and analyzed gene expression in thepositiveversusnegativecolonies.Thedatawerecombined with the previous hierarchical cluster analysis from Figure 5 and are shown in Figure 6 . Three clusters of colonies were identified: pluripotent, fibroblastic, and intermediate. It is clear that the GCTM-2/ CDH3 double-positive colonies cluster with the positive controls. In particular, these double-positive colonies show high levels of expression of the late upregulated genes such as HAS3, ENDRB, SOX2, FOXD3, CDH1, EPHA1, LCK, and CDH3 (gene cluster 1). CDH3-positive colonies also express earlier pluripotency markers including NANOG, POU5F1, DNMT3B, LEFTY1, NODAL, EPCAM, and TDGF1 (gene cluster 2) and show relatively consistent expression of markers associated with mesendoderm, including CER1, MIXL1, GSC, and T (gene cluster 3). By contrast, GCTM-2/EPCAM-or GCTM-2/CDH1-positive colonies at days 20 and 30 in the intermediate cluster showed less consistent expression of the genes in the late category.
Quantification of gene expression in selected colonies is shown in Figure 7 . GCTM-2/CDH3 double-positive colonies live-cell selected at day 30 (GP D30) demonstrate expression of both early and late upregulated genes similar to that of the positive control hiPSC and hESC colonies. In contrast to GCTM-2/EPCAM and TRA-1-60/ CDH1 colonies selected at day 30, GP D30 colonies had expression profiles more similar to the positive controls when comparing relative quantification values. The difference is most striking among the late upregulated gene set, which demonstrates a greater difference between GP D30 samples and those of all the remaining sample groups including the previous double-positive samples.
Live Colony Selection for CDH3 Staining Selects Fully Reprogrammed Cells
To determine whether gene expression in CDH3-positive colonies was predictive of their ability to yield permanent iPSC lines, and to determine whether CDH3 selection could be applied to other reprogramming methodologies, we compared selection using live-cell staining with CDH3 plus GCTM-2 to selection with EPCAM plus GCTM-2 following reprogramming with episomal vectors. Eight of eight CDH3/GCTM-2-positive colonies gave rise to permanent iPSC lines, whereas five of seven EPCAM/GCTM-2-positive colonies yielded permanent cell lines. All iPSC lines expressed pluripotent stemcell surface markers and pluripotency associated genes and could differentiate into cells expressing markers of all three embryonic germ layers in embryoid body (supplemental online Fig. 8 ) and neurosphere assays, with the exception of one CDH3/GCTM-2-selected line. This line (CDH3-CL5) generated TUBB3+ neurons (ectoderm) in neurospheres but failed to form robust EBs.
DISCUSSION
The process of reprogramming to pluripotency by defined factors has been subject to detailed molecular analysis [19] . Many studies have performed sequential analyses of the transcriptome and epigenome in mouse fibroblast cells reprogrammed by inducible constructs that drive facile and tightly regulated expression of reprogramming factors. Using cell surface markers and reporter genes, earlier studies have identified early and late phases of the reprogramming process, marked by distinct patterns of epigenetic change. The early phase is associated with the mesenchymal to epithelial transition, followed by an intermediate stage of activation of a subset of pluripotency genes, then a late stabilization phase marked by the onset of SOX2 expression [7, 20] . In the mouse, downregulation of the fibroblast cell surface marker Thy-1, and upregulation of the pluripotent stem cell marker SSEA-1, identify early stages of reprogramming [21, 22] . Recent work on mouse cells shows that downregulation of CD44 and activation of ICAM1 mark a late stage in the reprogramming process [23] . In mouse or human studies, GDF3 and NANOG are activated relatively early, whereas the pluripotency factor SOX2 has been consistently identified as a factor whose expression is activated in the later stages of reprogramming.
In the human, most studies have focused on SSEA-4 and TRA-1-60 as a marker for the enrichment of reprogrammed cells [8, 9, (Figure legend continued from previous page.) pluripotency markers expressed in most D20 and D30 positive cells plus ES cells and fully reprogrammed iPSCs but also in a significant proportion of marker-negative colonies. Gene cluster 3 is expressed in a subset of D30 positive cells as well as ES cells and fully reprogrammed iPSC but is absent from most negative colonies. Gene cluster 4 contains genes associated with mesendoderm that are expressed in some D30-positive colonies and ES and iPSC cells but not in negative colonies or FIBROs. Cluster 1 genes: ERBB3, DNMT3B, FOXD3; cluster 2 genes: DPPA3, NANOG, POU5F1, LEFTY1, NODAL, TDGF1; cluster 3 genes: CDH1, EPHA1, LCK, CDH3, SOX2, EDNRB, HAS3; cluster 4 genes: T, GSC, GATA4, MIXL1, CER1.
Color scale (top) shows DC T values. Abbreviations: D, day; ES, embryonic stem; FIBRO, fibroblast; hESC, human embryonic stem cell; hiPSC-F, fully reprogrammed hiPSC; hiPSC-P, partially reprogrammed hiPSC; iPSC, induced pluripotent stem cell. 24], more recently in conjunction with CD30 [10] . SSEA-4 is a cell surface glycolipid expressed on pluripotent stem cells and TRA-1-60 reacts with a glycolipid epitope present on large extracellular glycoprotein complex that contains the mucin-like protein podocalyxin [25] . CD30 is a member of the tumor necrosis factor receptor superfamily with very limited expression in adult tissues and whose expression in hiPSC is influenced by genetic and epigenetic alterations in the cells [26, 27] . These studies, like ours, consistently found that GDF3 and NANOG are activated early and that SOX2 expression occurs at a late stage of reprogramming.
We related expression of particular cell surface markers to activation of the pluripotency gene program during reprogramming of human fetal fibroblasts. We focused on the cell surface markers defined by monoclonal antibodies GCTM-2 and TRA-1-60, as well as EPCAM and CDH1. GCTM-2 and TRA-1-60 recognize related epitopes on a large cell surface glycoprotein complex of primate pluripotent stem cells [25] . EPCAM and CDH1 are well-characterized cell-cell adhesion molecules implicated in the maintenance of pluripotent stem cells in mice [28] [29] [30] . The genes we studied in our panel included known regulators of pluripotency as well as genes identified in our previous work as characteristic of a stem cell subpopulation with high self-renewal capacity, at the top of a hierarchy of cells showing a gradation in pluripotency gene expression [31, 32] . The reprogramming marker timeline experiment confirmed that intense staining for TRA-1-60 and EPCAM/CDH1 occurs only fairly late in the reprogramming process (TRA-1-60, human [9] ; EPCAM and CDH1, mouse [28] ). Likewise, the epitope defined by antibody GCTM-2 appears late during the reprogramming process.
The percentage of reprogramming foci exhibiting staining equivalent to positive controls reaches a maximum of approximately 10% for all surface markers by day 24. These data support the hypothesis that intense staining is representative of foci that are well on the pathway to reactivation of all the pluripotency networks necessary to reach a fully reprogrammed state. Expression of cell surface markers requires activation not only of the relevant transcriptional network but also appropriate posttranscriptional control and posttranslational modification.
Gene expression patterns can be related to cell surface marker staining within reprogramming foci. The early upregulated genes (POU5F1, NANOG, NODAL, CDH1, EPCAM, LEFTY1, TDGF1, and DNMT3B) all have well known roles in the maintenance of pluripotency [29, [33] [34] [35] [36] [37] [38] . These genes begin to be activated on approximately days 10-20 and are found in most foci by day 30, in contrast to the late upregulated group. All of the positive controls have high expression of these genes, but even at day 30, only some of the selected colonies exhibit expression of these genes. The activation of this group of genes, which includes FOXD3, CDH3, LCK, EPHA1, EDNRB, HAS3, and SOX2, marks a later stage in the reprogramming process and could thus be used to isolate colonies that have the highest probability of becoming fully reprogrammed hiPSCs.
Expression analysis of these genes indicates a highly statistically significant difference between day 30 double-positive foci (GCTM-2/EPCAM, TRA-1-60/CDH1) and the positive control fully reprogrammed hiPSCs and hESCs. More than half of the doublepositive foci were negative for expression of late reprogramming genes, suggesting that they have not completed the reprogramming process at this point. It is possible that the foci lacking expression of these genes would later exhibit expression, but the absence of expression after 4-5 weeks of reprogramming indicates a prolonged process that could be abortive. The role of many of these genes in stem cell regulation is unknown, but FOXD3 has been reported to be important in the maintenance of pluripotency. SOX2 has a well-established role in pluripotency and also serves as a late marker of reprogramming in the mouse.
On the basis of results with GCTM-2, TRA-1-60, EPCAM, and CDH1, we identified CDH3 as a cell surface marker that could select cells that had fully activated the panel of genes in our study. Selection with CDH3 achieved this outcome, with almost all GCTM-2/CDH3-positive colonies at day 30 expressing levels of all pluripotency related genes studied similar to positive controls. Consistent with this result, CDH3/GCTM-2 selection of colonies generated by transfection with episomal vectors encoding reprogramming factors gave rise to permanent iPSC lines with high frequency. Further comparative analysis with large-scale selection of reprogrammed foci will be required to determine whether selection with CDH3 provides a definitive advantage over other markers in the isolation of fully reprogrammed cells, but our data show clearly that CDH3-positive colonies have reached the end stage of the reprogramming process.
Recently Takahashi et al. [12] showed that during reprogramming of human fibroblasts, a subset of cells expressed markers of the primitive streak from approximately day 11 to day 28 after gene transfection. We too observed expression of MIXL, T, CER1, and GSC in cell surface marker-positive colonies on days 20-30, although we saw a similar level of expression of these genes in hESC and fully reprogrammed iPSC in this study and in a single-cell analysis of hESC gene expression [13] . It is possible that expression of these mesendodermal genes in our system is indicative of a degree of spontaneous differentiation or lineage priming in fully reprogrammed pluripotent cells. Spontaneous differentiation or lineage priming may have been absent in the positive control iPSC of Takahashi et al. [12] .
Cacchiarelli et al. [18] carried out extensive transcriptional and epigenomic analysis of the time course of reprogramming of human fibroblasts using an inducible transgene system. In their study, multidimensional scaling analysis distinguished SSEA-3-positive cells (appearing at day 10) from TRA-1-60-positive cells (appearing at day 20) , and both of these categories from fully reprogrammed cells. Most of the reprogramming experiments in our study were carried out under xeno-free conditions using human fibroblast feeder cells. The studies using selection with CDH3 were carried out using either xeno-free conditions or using mouse embryo feeder cells and medium supplemented with conventional knockout serum replacer and FGF2. Cacchiarelli et al. [18] used mouse embryo feeder cells and medium supplemented with conventional knockout serum replacer and FGF2 but used an inducible system and immortalized fibroblasts. Because these various systems yielded similar time courses of induction of gene expression, it is likely that the classification of early and late genes here is intrinsic to the reprogramming process. The time course of expression of our late genes in the study of Cacchiarelli et al. [18] analysis suggests that despite the use of different modalities of reprogramming, our CDH3-positive population would likely equate to the end stage of their process.
( Figure legend continued from previous page .) The vertical axis shows clustering of colonies, the horizontal axis, clustering of genes. Colonies fall into pluripotent, fibroblastic, or intermediate clusters. Gene cluster 1 is consistently expressed in CDH3/GCTM-2-positive colonies along with embryonic stem cells and fully reprogrammed iPSCs, but only in a subset of days 20 and 30 GCTM-2/EPCAM-and TRA-1-60/CDH1-positive colonies, and is largely absent from fibroblasts or negative colonies. Gene cluster 2 contains canonical pluripotency genes that are expressed consistently in all colony types except fibroblasts and marker negative colonies. Gene cluster 3 contains mesendodermal genes and is expressed in a substantial fraction of CDH3/GCTM-2-positive colonies and days 20 and 30 GCTM-2/EPCAM-and TRA-1-60/CDH1-positives along with embryonic stem cells and fully reprogrammed induced pluripotent stem cells, but is absent from negative colonies and FIBROs. Cluster 1 genes, HAS3, ENDRB, SOX2, FOXD3, CDH1, EPHA1, LCK, CHD3; cluster 2 genes, NANOG, POU5F1, LEFTY1, NODAL, EPCAM, TDGF1; cluster 3 genes, CER1, GATA4, MIXL1, GSC, T. Color scale (top) shows DC T values. Abbreviations: FIBRO, fibroblast; hESC, human embryonic stem cell; hiPSC-P, partially reprogrammed hiPSC; hiPSC-F, fully reprogrammed hiPSC; NEG, negative; POS, positive.
